Your session is about to expire
← Back to Search
Imaging
Healthy Volunteers for Heart Attack
Phase < 1
Waitlist Available
Led By David E. Sosnovik, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is looking at using MRI to see changes in heart structure in people at risk for heart failure. Patients will have serial MRI scans to look for changes over time.
Eligible Conditions
- Heart Attack
- Heart Failure
- Enlarged Heart
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Myofiber Helix Angle
Secondary study objectives
Correlation of Myofiber Helix Angle and Strain
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Active Control
Group I: Healthy VolunteersActive Control1 Intervention
DTI will be performed in healthy volunteers to characterize normal fiber architecture in the heart and provide a comparison group for the patients imaged in the other arms.
Group II: Patients with Recent Myocardial InfarctionActive Control2 Interventions
Patients with recent ST elevation myocardial infarcts will be recruited and imaged serially with DTI to detect changes in fiber architecture and their correlation with remodeling of the left ventricle.
Group III: Patients with Left Ventricular HypertrophyActive Control1 Intervention
Patients with left ventricular hypertrophy and a history of heart failure will be recruited and imaged serially with DTI to detect changes in fiber architecture and their correlation with the onset and progression of heart failure.
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
3,006 Previous Clinical Trials
13,307,122 Total Patients Enrolled
David E. Sosnovik, MDPrincipal InvestigatorMassachusetts General Hospital
Share this study with friends
Copy Link
Messenger